Recent Posts
- Tanvex BioPharma Completes Acquisition of Bora Biologics, Launching New Era in Biologics Development
- Bora Company Presentation at 43rd Annual J.P. Morgan Healthcare Conference
- Bora Biologics Announces Strategic Collaboration to Accelerate Key CMC Development of DotBio’s Tri-Specific Antibody to Treat Cancer
- Bora Pharmaceuticals Announces Unveiling of New Multi-Purpose Small Molecule Site in Zhongli, Taiwan
- Bora Pharmaceuticals Wins Dual Honors at the Taiwan MAPECT M&A Ceremony: “Deal of the Year” Award and “Best Cross-Border M&A” Award